FDA approves Amgen's Humira biosimilar AMJEVITA™ for treatment of seven inflammatory diseases

Medium_images

FDA approved Amgen's Humira biosimilar AMJEVITA™ for treatment of seven inflammatory diseases.

Published at Amgen's News releases (https://www.amgen.com/media/news-releases/ ) on September 23, 2016.  Read more >

 

Return to Pharma News